Condition
Hypotonia
Total Trials
6
Recruiting
1
Active
1
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
2 of 4 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (5)
Trial Status
Completed4
Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT03492060Recruiting
Longitudinal Study of Neurogenetic Disorders
NCT03548779Not ApplicableCompleted
North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2
NCT04846400Not ApplicableCompleted
Pilot Study of a Self-Supporting Nasopharyngeal Airway in Hypotonia
NCT03852004Not ApplicableUnknownPrimary
Osteopathic Treatment on Motor Development of Hypotonic Infants.
NCT05391594Not ApplicableCompleted
Effect of Trunk Support on Academic Engagement of Children With Severe Disability
NCT04894799Not ApplicableCompleted
Vestibular Stimulation and Neurodevelopmental Technique on Hypotonic Cerebral Palsy While Controlling the Gender
Showing all 6 trials